The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode

OBJECTIVE: To assess the safety and effectiveness of open-label treatment with extended-release carbamazepine (ERC) in pediatric subjects suffering from bipolar I disorder. METHOD: Medically healthy youths aged 10–17 years suffering from an acute manic or mixed episode were eligible. After screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Findling, Robert L, Ginsberg, Lawrence D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156006/
https://www.ncbi.nlm.nih.gov/pubmed/25210452
http://dx.doi.org/10.2147/NDT.S68951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156006/
https://www.ncbi.nlm.nih.gov/pubmed/25210452
http://dx.doi.org/10.2147/NDT.S68951

Ejemplares similares